364 related articles for article (PubMed ID: 22920324)
1. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics.
Perry JL; Reuter KG; Kai MP; Herlihy KP; Jones SW; Luft JC; Napier M; Bear JE; DeSimone JM
Nano Lett; 2012 Oct; 12(10):5304-10. PubMed ID: 22920324
[TBL] [Abstract][Full Text] [Related]
2. The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles.
Gao H; Liu J; Yang C; Cheng T; Chu L; Xu H; Meng A; Fan S; Shi L; Liu J
Int J Nanomedicine; 2013; 8():4229-46. PubMed ID: 24235825
[TBL] [Abstract][Full Text] [Related]
3. In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content.
Sheng Y; Yuan Y; Liu C; Tao X; Shan X; Xu F
J Mater Sci Mater Med; 2009 Sep; 20(9):1881-91. PubMed ID: 19365612
[TBL] [Abstract][Full Text] [Related]
4. The effects of oil-in-water nanoemulsion polyethylene glycol surface density on intracellular stability, pharmacokinetics, and biodistribution in tumor bearing mice.
Hak S; Garaiova Z; Olsen LT; Nilsen AM; de Lange Davies C
Pharm Res; 2015 Apr; 32(4):1475-85. PubMed ID: 25348468
[TBL] [Abstract][Full Text] [Related]
5. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
[TBL] [Abstract][Full Text] [Related]
6. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
7. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
8. Dense and Dynamic Polyethylene Glycol Shells Cloak Nanoparticles from Uptake by Liver Endothelial Cells for Long Blood Circulation.
Zhou H; Fan Z; Li PY; Deng J; Arhontoulis DC; Li CY; Bowne WB; Cheng H
ACS Nano; 2018 Oct; 12(10):10130-10141. PubMed ID: 30117736
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
10. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
[TBL] [Abstract][Full Text] [Related]
11. PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils.
Kelley WJ; Fromen CA; Lopez-Cazares G; Eniola-Adefeso O
Acta Biomater; 2018 Oct; 79():283-293. PubMed ID: 30195083
[TBL] [Abstract][Full Text] [Related]
12. Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats.
Ozcan I; Segura-Sánchez F; Bouchemal K; Sezak M; Ozer O; Güneri T; Ponchel G
Int J Nanomedicine; 2010 Dec; 5():1103-11. PubMed ID: 21270961
[TBL] [Abstract][Full Text] [Related]
13. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.
Peracchia MT; Fattal E; Desmaële D; Besnard M; Noël JP; Gomis JM; Appel M; d'Angelo J; Couvreur P
J Control Release; 1999 Jun; 60(1):121-8. PubMed ID: 10370176
[TBL] [Abstract][Full Text] [Related]
14. PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent.
Fahrländer E; Schelhaas S; Jacobs AH; Langer K
Nanotechnology; 2015 Apr; 26(14):145103. PubMed ID: 25789544
[TBL] [Abstract][Full Text] [Related]
15. Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration.
Semete B; Booysen L; Kalombo L; Ramalapa B; Hayeshi R; Swai HS
Int J Pharm; 2012 Mar; 424(1-2):115-20. PubMed ID: 22227605
[TBL] [Abstract][Full Text] [Related]
16. Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier.
Chaudhari KR; Ukawala M; Manjappa AS; Kumar A; Mundada PK; Mishra AK; Mathur R; Mönkkönen J; Murthy RS
Pharm Res; 2012 Jan; 29(1):53-68. PubMed ID: 21744174
[TBL] [Abstract][Full Text] [Related]
17. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.
Suk JS; Xu Q; Kim N; Hanes J; Ensign LM
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):28-51. PubMed ID: 26456916
[TBL] [Abstract][Full Text] [Related]
18. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study.
Kah JC; Wong KY; Neoh KG; Song JH; Fu JW; Mhaisalkar S; Olivo M; Sheppard CJ
J Drug Target; 2009 Apr; 17(3):181-93. PubMed ID: 19016072
[TBL] [Abstract][Full Text] [Related]
19. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo.
Du XJ; Wang JL; Liu WW; Yang JX; Sun CY; Sun R; Li HJ; Shen S; Luo YL; Ye XD; Zhu YH; Yang XZ; Wang J
Biomaterials; 2015 Nov; 69():1-11. PubMed ID: 26275857
[TBL] [Abstract][Full Text] [Related]
20. Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation.
Yang Q; Jones SW; Parker CL; Zamboni WC; Bear JE; Lai SK
Mol Pharm; 2014 Apr; 11(4):1250-8. PubMed ID: 24521246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
